Trk receptor inhibitor Selitrectinib, Purity ≥98%

Cat. No.: X24-06-ZQ385

Trk receptor inhibitor Selitrectinib, Purity ≥98%

Synonym: 2097002-61-2; Trk receptor inhibitor; LOXO-195; LOXO 195; LOXO 195

  • CAS Number: 2097002-61-2
  • Compound CID: 129103609
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Selitrectinib, soluble in DMSO and ethanol and insoluble in water, blocks the activity of tropomyosin receptor kinases, which are involved in the growth and survival of neurons. It targets TrkA and TrkB.
Molecular Weight
380.42
Molecular Formula
C20H21FN6O
Targets
TrkA: 0.6 nM; TrkB: <2.5 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 35 mg/mL (91.99 mM); Water: Insoluble; Ethanol: 14 mg/mL (36.8 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Selitrectinib is used to research its precision inhibition of TRK fusion proteins in cancer, supporting targeted oncological therapy studies.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0